Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
During this open label study patients will receive IMM-101 in conjunction with a recognised standard of care for metastatic or unresectable cancer for the patient’s specific tumour type. The primary objective of the study is to provide safety data for IMM-101 in combination with a number of selected standard of care regimens.
创建时间：
2017-05-15
